Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

HT942524ATRPCRA: DoD Arthritis Research, Clinical Research Award

Closed Closed October 30, 2024 Opportunity HT942524ATRPCRA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2024.

• Total funding$6.0 million
• Expected awards3
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY24 ATRP CRA is intended to support clinical research that evaluates disease-specific factors and interventions. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing all types of arthritis is encouraged including but not limited to osteoarthritis, post-traumatic arthritis, inflammatory arthritis, juvenile arthritis, or rheumatoid arthritis. The ATRP encourages applications that address sex as a biological variable and understudied arthritis types. The ATRP also encourages applicants to consider whether large data sets or existing studies/consortia can be leveraged to maximize the potential impact of the proposed research. Applicants must address how the proposed research will impact patient care and reduce the burden of disease. It is expected that any research findings would benefit Service Members, Veterans, their Families, and the general public. To meet the intent of the award mechanism, applications must specifically address at least one FY24 ATRP CRA focus area, listed in Section II.A.1, above. Important aspects of this award mechanism include: • Impact: The application should explicitly state how outcomes of the proposed research will have a significant impact on arthritis disease management, patient care, and quality of life. • Military Relevance: The application should clearly describe how the research addresses the impact of arthritis in the military, which may include its effect on Service Member recruitment, retention, and recovery. Applicants may also choose to include impacts to the Military Health System, which provides health care support to Service Members and their Families (Eligibility | TRICARE). • Post-Award Transition Plan: The application should include the plan by which knowledge gained after successful completion of the award will be implemented in guidelines, communicated to relevant stakeholders, or move to the next phase of development. • Clinical Trial (CT) Option: The FY24 ATRP CRA offers a clinical trial option that provides support to accommodate the costs of a clinical trial. Applications proposing only a clinical trial or proposing clinical research that includes a clinical trial within the period of performance may select the Clinical Trial Option. A description of the standard of care and justification of any control groups must be included in the application.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.